The Effects of Adding TCM-700C on the Standard Combination Treatment for HCV Genotype 1 Patients(Phase III)

NCT01890200 · clinicaltrials.gov ↗

PHASE3

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: Peginterferon alfa-2a
DRUG: Ribavirin
DRUG: TCM-700C
DRUG: Placebo

Sponsor

TCM Biotech International Corp.